Chimerix
new cases of annually in the top markets market opportunity is a rapidly progressive disease with low survival rates few drug approvals last years existing therapies rarely offer durable effect retains global operational rights to market opportunity exceeds out of | Chimerix
Company
Deck date
August 2023
Slide
36 of 43
Similar slides by Chimerix
Investor Presentation
May 2023
Investor Presentation
March 2023
Related slides by other companies
SPAC
March 2022
Shareholder Engagement
May 2023
Investor Presentation
December 2023
Other recent decks by Chimerix
Investor Presentation
May 2023
Investor Presentation
March 2023
Results
March 2022
Investor Conference
November 2021
Search Thousands of Presentations by World Leading Companies